Category Archives: Drugs

Tulisa's ex-boyfriend Fazer reacts to drugs joke, The X Factor judges return and Will Smith remix! Forget reading -- who needs to'do words' when you can digest all things celebrity in under two minutes? All you have to do is hit play and sit there with yo... By: dailymirror … Continue reading →

Hepatitis C miracles- courtesy of "me-too" drugs News from the American Council on Science and Health. By: ACSHonTV … Continue reading →

The Affects of Drugs and Alcohol project - Health 2th hour By: Rafeal chef … Continue reading →

Lawmakers ban use of synthetic drugs The new law makes it illegal to possess dozens of man-made chemical compounds and variations of traditional drugs like methamphetamine or LSD. By: ketvtv … Continue reading →

SURGEON IS ON DRUGS - Surgeon Simulator 2013 Help us make a Tobuscus game! http://igg.me/at/tobuscus LIMITED TIME TobyGames Lootcrate! https://www.indiegogo.com/projects/tobuscus-adventures-the-game-by-... By: TobyGames … Continue reading →

Military Taking Drugs to Stay Awake for 90 Hours "All over the world, scientists are experimenting on soldiers to keep them awake beyond the limits of normal endurance. Researchers are engineering, and mili... By: TheYoungTurks … Continue reading →

The Voice star Joel Madden. Source: news.com.au Reality TV star and musician Joel Madden has been asked to leave his Australian home at The Star casino after drugs were found in his home, Channel 7 reports. CHARGES have not been laid against The Voice star and Silver Logie winner Joel Madden, who was allegedly found in possession of marijuana at his Sydney apartment on the weekend. Police have confirmed they executed a search warrant on Madden's serviced apartment at The Darling hotel, inside The Star casino complex, at about 10.30pm on Sunday night. "During the search a small amount of plant product, believed to cannabis, was found," a police spokesman said. "A 34-year-old man who occupies the apartment was present during the search. No charges have been laid." Channel Seven have reported that police had been alerted to the site by a cleaner. Madden was in possession of 5g of the drug, which isn't enough for a charge. In NSW, any person found with 15g or less of marijuana is issued with a caution. Madden has reportedly been ordered to quit his Sydney penthouse apartment. Read more from the original source: Drugs found in Madden's hotel room … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/fllmw4/global) has announced the addition of the "Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market 2012-2016" report to their offering. TechNavio's analysts forecast the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market to grow at a CAGR of 3 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in prevalence of the MRSA infection. The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market has also been witnessing the increase in Governmental/Non-Governmental awareness programs. However, the increasing generic competition could pose a challenge to the growth of this market. The key vendors dominating this market space are Pfizer Inc., Cubist Pharmaceuticals Inc., ViroPharma Inc., Theravance Inc. and Forest Laboratories Inc. The other vendors mentioned in the report are Basilea Pharmaceutica Ltd., Durata Therapeutics, Inc., Novartis AG, Trius Therapeutics, Inc., AstraZeneca plc., and GlaxoSmithKline plc. TechNavio recognizes the following companies as the key players in the Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market: Pfizer Inc., Cubist Pharmaceuticals Inc., ViroPharma Inc., Forest Laboratories Inc., and Theravance Inc. Commenting on the report, an analyst from TechNavio's Healthcare team said: 'The most common trend witnessed in the Global MRSA Drugs market is various governmental … Continue reading →

NEW YORK, June 10, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Orphan Drugs Focus on Biologics http://www.reportlinker.com/p01351953/Global-Markets-for-Orphan-Drugs--Focus-on-Biologics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication INTRODUCTION STUDY OBJECTIVES The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview of the current and future global market for orphan drugs. The key objective is to present a comprehensive analysis of current orphan drugs and those under development as important therapies and treatments for rare diseases. This report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market. The market for each drug listed by its generic name/active ingredient and approved indication(s) is also analyzed in this report. A detailed analysis of the structure of the orphan drug industry has been conducted. Revenues are broken down by region drug type (i.e., biological and nonbiological), active ingredient and area of medical application. Sales figures are estimated for the five-year period from 2012 through 2017. Applications for orphan drugs are also discussed in the report, with an … Continue reading →

NEW YORK, June 10, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Orphan Drugs Focus on Non-Biologics http://www.reportlinker.com/p01351954/Global-Markets-for-Orphan-Drugs--Focus-on-Non-Biologics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication INTRODUCTION STUDY OBJECTIVES The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. BCC's goal in conducting this study is to provide an overview of the current and future global market for orphan drugs. The key objective is to present a comprehensive analysis of current orphan drugs and those under development as important therapies and treatments for rare diseases. This report explores present and future strategies and regulations within the orphan drug market, advances in the market, the setbacks, the current situation and the needs of the market. The market for each drug listed by its generic name/active ingredient and approved indication(s) is also analyzed in this report. A detailed analysis of the structure of the orphan drug industry has been conducted. Revenues are broken down by region drug type (i.e., biological and nonbiological), active ingredient and area of medical application. Sales figures are estimated for the five-year period from 2012 through 2017. Applications for orphan drugs are also discussed in the report, with an … Continue reading →